0000880771-17-000067.txt : 20170424
0000880771-17-000067.hdr.sgml : 20170424
20170424195519
ACCESSION NUMBER: 0000880771-17-000067
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170420
FILED AS OF DATE: 20170424
DATE AS OF CHANGE: 20170424
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SCICLONE PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000880771
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943116852
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 950 TOWER LANE
STREET 2: SUITE 900
CITY: FOSTER CITY
STATE: CA
ZIP: 94404-2125
BUSINESS PHONE: 650-358-3456
MAIL ADDRESS:
STREET 1: 950 TOWER LANE
STREET 2: SUITE 900
CITY: FOSTER CITY
STATE: CA
ZIP: 94404-2125
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Blobel Friedhelm
CENTRAL INDEX KEY: 0001363213
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19825
FILM NUMBER: 17779360
MAIL ADDRESS:
STREET 1: 950 TOWER LANE, SUITE 900
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
4
1
certent-form4.xml
PRIMARY DOCUMENT
X0306
4
2017-04-20
0000880771
SCICLONE PHARMACEUTICALS INC
SCLN
0001363213
Blobel Friedhelm
950 TOWER LANE, SUITE 900
FOSTER CITY
CA
94404
1
1
0
0
President & CEO
Common Stock
2017-04-20
4
M
0
11678
3.55
A
104204
D
Common Stock
2017-04-20
4
S
0
11678
9.6002
D
92526
D
Common Stock
2017-04-21
4
M
0
16162
3.55
A
108688
D
Common Stock
2017-04-21
4
S
0
16162
9.4747
D
92526
D
Common Stock
2017-04-24
4
M
0
12160
3.55
A
104686
D
Common Stock
2017-04-24
4
S
0
12160
9.6405
D
92526
D
Non-Qualified Stock Options (right to buy)
3.55
2017-04-20
4
M
0
11678
0
D
2020-03-05
Common Stock
11678
238722
D
Non-Qualified Stock Options (right to buy)
3.55
2017-04-21
4
M
0
16162
0
D
2020-03-05
Common Stock
16162
222560
D
Non-Qualified Stock Options (right to buy)
3.55
2017-04-24
4
M
0
12160
0
D
2020-03-05
Common Stock
12160
210400
D
The reported sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 18, 2016.
Granted under the Issuer's 2005 Equity Incentive Plan.
25% of each shares vest one year from the date of grant, of March 5, 2010, and 2.0833% vests each month thereafter, provided that Reporting Person continues to be employed by the Issuer.
/s/ Friedhelm Blobel, Ph.D.
2017-04-24